Outlook Therapeutics, Inc. (OTLK)
0.5476
-0.01
(-2.46%)
USD |
NASDAQ |
Jan 14, 16:00
0.54
-0.01
(-1.39%)
After-Hours: 17:25
Outlook Therapeutics EPS Diluted (Quarterly): -0.5453 for June 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 0.2294 |
| Amicus Therapeutics, Inc. | 0.0558 |
| Neogen Corp. | -0.0732 |
| CorMedix, Inc. | 1.259 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -20.15M |
| Revenue (Quarterly) | 1.505M |
| Total Expenses (Quarterly) | 21.66M |
| Enterprise Value | 61.79M |
| Gross Profit Margin (Quarterly) | 68.83% |
| Profit Margin (Quarterly) | -1.34K% |
| Earnings Yield | -199.3% |
| Normalized Earnings Yield | -401.11 |